BeOne Medicines
ONC
#542
Rank
โ‚น4.364 T
Marketcap
โ‚น38,212
Share price
5.09%
Change (1 day)
30.96%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2023 (TTM): -โ‚น1,365

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น561.49. In 2022 the company made an earnings per share (EPS) of -โ‚น1,819 a decrease over its 2021 EPS that were of -โ‚น1,428.

EPS history for BeOne Medicines from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น1,365-24.94%
2022-โ‚น1,81927.35%
2021-โ‚น1,428-19.96%
2020-โ‚น1,78420.81%
2019-โ‚น1,47731.52%
2018-โ‚น1,123417.57%
2017-โ‚น216.97-37.16%
2016-โ‚น345.30158.95%
2015-โ‚น133.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น8.45-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น89.20-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA